within Pharmacolibrary.Drugs.ATC.N;

model N06AX18
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.94,
    Cl             = 0.056666666666666664,
    adminDuration  = 600,
    adminMass      = 0.004,
    adminCount     = 1,
    Vd             = 0.026,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Reboxetine is a selective norepinephrine reuptake inhibitor (NRI) used for the treatment of major depressive disorder. It is approved in several countries (e.g., some countries in Europe, but not the United States) for adult patients with depression.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Pellizzoni, C, et al., &amp; Strolin Benedetti, M (1996). Pharmacokinetics of reboxetine in healthy volunteers. Single against repeated oral doses and lack of enzymatic alterations. <i>Biopharmaceutics &amp; drug disposition</i> 17(7) 623–633. DOI:<a href=&quot;https://doi.org/10.1002/(SICI)1099-081X(199610)17:7&lt;623::AID-BDD978&gt;3.0.CO;2-S&quot;>10.1002/(SICI)1099-081X(199610)17:7&lt;623::AID-BDD978&gt;3.0.CO;2-S</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8894119/&quot;>https://pubmed.ncbi.nlm.nih.gov/8894119</a></p></li><li><p>Fleishaker, JC (2000). Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression. <i>Clinical pharmacokinetics</i> 39(6) 413–427. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200039060-00003&quot;>10.2165/00003088-200039060-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11192474/&quot;>https://pubmed.ncbi.nlm.nih.gov/11192474</a></p></li><li><p>Frigerio, E, et al., &amp; Dostert, P (1997). Pharmacokinetics of reboxetine enantiomers in the dog. <i>Chirality</i> 9(3) 303–306. DOI:<a href=&quot;https://doi.org/10.1002/(SICI)1520-636X(1997)9:3&lt;303::AID-CHIR17&gt;3.0.CO;2-R&quot;>10.1002/(SICI)1520-636X(1997)9:3&lt;303::AID-CHIR17&gt;3.0.CO;2-R</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9176997/&quot;>https://pubmed.ncbi.nlm.nih.gov/9176997</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N06AX18;
